Clinical Trial Update: A Study of Ritonavir-Boosted Danoprevir (RO5190591) in Combination With Pegasys and Ribavirin in Patients With Chronic Hepatitis C Genotype 1 [Phase 1]

View source ↗

Summary

Phase 1 trial of ritonavir-boosted danoprevir with Pegasys and ribavirin for chronic hepatitis C genotype 1 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)
• RO5190591 ritonavir-boosted danoprevir (ritonavir-boosted danoprevir; danoprevir boosted with ritonavir)
• Ribavirin (ribavirin)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis C, Chronic | Phase 1 | Status: COMPLETED